Back to Search
DAVID EILENDER, MD
MD
Hematology & Oncology Physician
NPI: 1700823705IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
4301405809(MI)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1985
Research & Publications (6)
4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.
PMID 16184382·Cancer Chemother Pharmacol·2006
3-trial
Factors affecting bryostatin 1-enhanced 2-CdA cytotoxicity in resistant B-cell chronic lymphocytic leukemia.
PMID 15202025·Int J Mol Med·2004
8-other
Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
PMID 12893763·Blood·2003
7-preclinical
Blastic natural killer cell lymphoma/leukemia: a report of seven cases.
PMID 11789729·Am J Clin Pathol·2002
5-case
CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
PMID 11488062·Am J Clin Pathol·2001
5-case
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
PMID 10741703·Clin Cancer Res·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 240 HOSPITAL PL
SOLDOTNA, AK 99669 - Phone
- (907) 714-5611
Quick Facts
- NPI
- 1700823705
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 6
Are you this provider?
Claim Your Profile